Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Real-World Evidence: ‘Labor-Intensive’ Data Standardization May Be Required By US FDA
Oct 22 2021
•
By
Derrick Gingery
Because real-world data comes from different sources, terminology and other items have to be standardized in order to be analyzed. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Real-World Evidence
More from Clinical Trials